All tenders
HHSN268201600038C
IGF::OT::IGF THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES.
National Institutes of Health · United States
This tender closed on Tuesday, March 22, 2022. Browse open opportunities
Time Left to Bid
Closed
ClosedOtherFederal
Basic information
- Reference number
- HHSN268201600038C
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- IGF::OT::IGF THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES.
- Source
- USASpending (Federal)
- Source ID
- usa-HHSN268201600038C
Details
- Location
- United States
Description
IGF::OT::IGF THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES. Awarded to: PEDIASTENT LLC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2016/09/26 12:00:00 AM UTC
- Closing date
- 2022/03/22 12:00:00 AM UTC
Estimated value
$3.4M USD
Classification
Normalized category
Other